Treatment options for Crohn’s disease tend to focus on symptom control, but new research highlights a potential treatment option that targets a pathway in the immune system itself.
Scientists at Case Western Reserve University School of Medicine in Cleveland, OH, have published the results of their 3-year study in the journal Cellular and Molecular Gastroenterology and Hepatology.
Crohn’s disease is a type of inflammatory bowel disease (IBD) that causes chronic inflammation of the gastrointestinal tract.
Current treatment options help alleviate symptoms and manage remission, but scientists are still researching targeted treatment.
The new study focused on just that. It investigated the chronic inflammation that people genetically prone to Crohn’s disease often experience.
Read the full report from Medical News Today.